All Articles

Lucara Diamond Corp. finalizes a massive financing package for its Karowe mine expansion, averting a crisis but taking on costly debt to secure its future.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

Colgate-Palmolive signals confidence with its 63rd annual dividend hike and appoints Bristol Myers Squibb's CEO to its board, a strategic health pivot.

After a tough 2025, the gaming giant touts record margins and an aggressive 2026 plan, betting on new gear and a massive market catalyst for growth.

PitchBook integrates its private market data into Perplexity's AI, promising a new era of fast, verifiable, and conversational financial intelligence.

Maker's Pride is closing two Midwest facilities as part of a strategic shift to automation, leaving communities in Utah and Minnesota facing an uncertain future.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.

A manufacturing flaw in some Omnipod 5 insulin pods has caused serious health issues, prompting a company response and raising questions about device safety.

The Joint Corp. posts higher profits through a major franchise pivot, but declining patient visits and sales raise questions about its long-term health.

As FGI Industries prepares its 2025 results, investors watch for clues on the health of the home improvement sector amid economic uncertainty.

Strathcona Resources to repurchase up to 5% of its shares, calling them undervalued. The move signals strong confidence and boosts shareholder value.

A coalition of 20 organizations has petitioned the state to ban lead ammunition, citing overwhelming evidence of harm to eagles, wildlife, and humans.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

BNP Paribas more than doubles its scholarship program, awarding $200,000 to ten local high school tennis players and fueling their college dreams.

With a new strategic finance leader, MATEREAL signals a shift from R&D to aggressive commercialization of its 'drop-in' AI-enabled bio-polymers.

AdVini acquires key assets from Cordier By InVivo, including Café de Paris, in a strategic move to combat market decline and expand into sparkling wine.

USA Cycling names Shokz its official headphones, a landmark deal promoting open-ear audio technology to enhance cyclist safety and community engagement.

A legislative movement across 11 states aims to make scalp cooling, a therapy to prevent hair loss during chemo, an insured part of cancer treatment.

A landmark housing bill meant to ease affordability faces fierce opposition for a new rule that could stifle rental construction and drive up costs.